Leuprolide acetate
IA0047
Phase 2 small_molecule completed
Quick answer
Leuprolide acetate for Alzheimer Disease is a Phase 2 program (small_molecule) at Voyager Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Voyager Therapeutics
- Indication
- Alzheimer Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed